Experimental studies on bacterial product CANTASTIM derived from Pseudomonas aeruginosa. II. Protective effect in Salmonella typhimurium infection.
Stimulation of the host defense system in a nonspecific way may provide effective treatment of recurrent infections. CANTASTIM is a bacterial product that has been successfully used in cancer immunotherapy as well as in chronic infections treatment. The nonspecific protective effect of CANTASTIM was investigated in two models of experimental infection with Salmonella typhimurium in mice. Prophylactic administration of CANTASTIM (three days before challenge) enhanced peritoneal macrophages bactericidal activity and significantly increased survival of treated mice. When CANTASTIM was administered 72 h after bacterial challenge, in a sublethal infection model with Salmonella typhimurium, by activating macrophages, NK and T cells, it increased the survival rate. The cell populations and molecular mechanisms involved in the prophylactic and therapeutic protective effect CANTASTIM seem to be partially different.
Salageanu
A
A
Immunology Department, Cantacuzino Institute, Bucharest, Romania.
Ceacareanu
B
B
Popescu
D
D
Istrate
N
N
Szegli
G
G
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D051379:Mice; D010743:Phospholipids; D011550:Pseudomonas aeruginosa / Q000737:chemistry*; D012481:Salmonella Infections, Animal / Q000188:drug therapy / Q000517:prevention & control*
D000276:Adjuvants, Immunologic; D010743:Phospholipids; C049675:cantastim